Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 388

The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.

ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment

Open access
Gordon, Hannah, Minozzi, Silvia, Kopylov, Uri, Verstockt, Bram, Chaparro, María, Buskens, Christianne, Warusavitarne, Janindra, Agrawal, Manasi, Allocca, Mariangela, Atreya, Raja, Battat, Robert, Bettenworth, Dominik, Bislenghi, Gabriele, Brown, Steven Ross, Burisch, Johan, Casanova, María José, Czuber-Dochan, Wladyslawa, de Groof, Joline, El-Hussuna, Alaa, Ellul, Pierre, Fidalgo, Catarina, Fiorino, Gionata, Gisbert, Javier P, Sabino, João Guedelha, Hanzel, Jurij, Holubar, Stefan, Iacucci, Marietta, Iqbal, Nusrat, Kapizioni, Christina, Karmiris, Konstantinos, Kobayashi, Taku, Kotze, Paulo Gustavo, Luglio, Gaetano, Maaser, Christian, Moran, Gordon, Noor, Nurulamin, Papamichael, Konstantinos, Peros, Georgios, Reenaers, Catherine, Sica, Giuseppe, Sigall-Boneh, Rotem, Vavricka, Stephan R, Yanai, Henit, Myrelid, Pär, Adamina, Michel, Raine, Tim·2024·Journal of Crohn's and Colitis

Abstract

Crohn’s disease [CD] is a chronic inflammatory bowel disease [IBD] that can result in progressive bowel damage and disability.1 CD can affect individuals of any age, from children to the elderly,2,3 and may cause significant morbidity and impact on quality of life [QoL]. The precise aetiology of CD remains unknown and a curative therapy is not yet available. Contemporary therapy therefore is focused on control of inflammation, using medications along with timely surgical interventions to alleviate the symptoms of bowel damage. The European Crohn’s and Colitis Organisation [ECCO] produces several guidelines aimed at providing evidence-based guidance on critical aspects of IBD care. In 2020, ECCO published new guidelines on the management of CD in two manuscripts focused on the medical and surgical management of disease.4,5 For the 2020 CD guidelines, ECCO adopted the Grading of Recommendations Assessment, Development, and Evaluation [GRADE] approach, a systematic process for developing guidelines that addresses how to frame the health care questions, summarise the evidence, formulate the recommendations, and grade their strength and quality of associated evidence.6 The present manuscript represents an update to the 2020 guidelines and is focused specifically on medical management of CD, and a companion manuscript developed as part of the same process addresses optimal surgical management.5 We take a drug-by-drug approach to review the evidence for various medical and dietary strategies used in the management of CD. For this iteration of the guidelines, we have introduced several new, clinically relevant questions as chosen by members of the guidelines group, a systematic approach to reviewing and updating previous topics to incorporate any new evidence, and a reappraisal of all evidence in the context of contemporary practice. We have also introduced several ‘practice points’ to summarise evidence, and expert recommendations in certain key areas of practice where the evidence base is limited but where clinicians and patients need to make decisions nonetheless. Here, where application of the GRADE methodology might be impractical, we have used an approach based on systematic literature review, expert discussion, and voting to form consensus recommendations outside the formal GRADE process. It is important to remember that achieving optimal outcomes in CD relies not just on knowledge of the appropriate use of current medical and surgical therapies but also on careful attention to wider aspects of management, including early diagnosis, prompt initial management,7 close monitoring of treatment response, and psychological and dietary support.8 The development of these guidelines followed the GRADE workflow, as adopted in previous ECCO guidelines.9 A panel of 46 experts were selected from an open call according to criteria based on IBD expertise, scientific background, knowledge of GRADE methodology, and prior contribution to ECCO projects. Additionally, six patients with CD selected by the European Federation of Crohn’s and Colitis Associations [EFFCA] were invited to participate in discussions. The group was supported in their work by a team of professional methodologists and librarians. The panellists first agreed on a list of questions using the Population, Intervention, Comparator, Outcomes [PICO] format. PICO questions addressed as part of the 2020 ECCO CD guidelines were reviewed and considered for retention with regards to ongoing relevance, and new PICO questions were formulated, discussed, and added to the list. The relevant outcomes for all PICO questions were graded according to importance using a Delphi consensus process. Note that for PICO questions retained from 2020, the importance of the outcomes was nonetheless revised according to the results of this new consensus. The professional librarians next performed a comprehensive literature search on EMBASE, PubMed/Medline, and Cochrane Central databases, using specific search strings developed for each PICO question [Supplementary files available as Supplementary data at ECCO-JCC online]. For PICO questions retained from the 2020 guidelines, the same search string was used as during the prior literature search, and the start date of database queries set to the same as the end search date for the previous guidelines 1 April 2018. For all new PICO questions, the search start date was unlimited. Two independent consensus group members assessed the relevance of each abstract to the PICO and included or excluded all the relevant papers for the final data extraction and analysis. Subsequently, group members systematically reviewed and summarised the evidence on every outcome voted as ‘important’ or ‘critical’, to compile a Summary of Findings [SoF] table for each question, or updated the prior SoF tables from 2020 [including revision according to any changes to outcomes deemed critical or important]. We adopted a standard hierarchical approach, searching fo

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ecco-jcc/jjae091

Cites

167 of 167 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 167 references

Metadata

Authors
Gordon, H., Minozzi, S., Kopylov, U., Verstockt, B., Chaparro, M., Buskens, C., Warusavitarne, J., Agrawal, M., Allocca, M., Atreya, R., Battat, R., Bettenworth, D., Bislenghi, G., Brown, S. R., Burisch, J., Casanova, M. J., Czuber-Dochan, W., de Groof, J., El-Hussuna, A., Ellul, P., Fidalgo, C., Fiorino, G., Gisbert, J. P., Sabino, J. G., Hanzel, J., Holubar, S., Iacucci, M., Iqbal, N., Kapizioni, C., Karmiris, K., Kobayashi, T., Kotze, P. G., Luglio, G., Maaser, C., Moran, G., Noor, N., Papamichael, K., Peros, G., Reenaers, C., Sica, G., Sigall-Boneh, R., Vavricka, S. R., Yanai, H., Myrelid, P., Adamina, M., & Raine, T.
Venue
Journal of Crohn's and Colitis
Published
2024-06-15
Volume
18
Issue
10
Pages
1531-1555
ISSN
  • 1873-9946 (ISSN-L)
  • 1876-4479
OpenAlex
W4399701762
Cited by
388
References
167
FWCI
93.61
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment. https://app.cochat.ai/papers/10.1093/ecco-jcc/jjae091
The paper
Gordon, H., Minozzi, S., Kopylov, U., Verstockt, B., Chaparro, M., Buskens, C., Warusavitarne, J., Agrawal, M., Allocca, M., Atreya, R., Battat, R., Bettenworth, D., Bislenghi, G., Brown, S. R., Burisch, J., Casanova, M. J., Czuber-Dochan, W., de Groof, J., El-Hussuna, A., . . . Raine, T. (2024). ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment. Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjae091

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.